BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li P, Du R, Wang Y, Hou X, Wang L, Zhao X, Zhan P, Liu X, Rong L, Cui Q. Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors. Front Microbiol 2020;11:182. [PMID: 32256457 DOI: 10.3389/fmicb.2020.00182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Yin H, Jiang N, Shi W, Chi X, Liu S, Chen JL, Wang S. Development and Effects of Influenza Antiviral Drugs. Molecules 2021;26:810. [PMID: 33557246 DOI: 10.3390/molecules26040810] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Li P, Du R, Chen Z, Wang Y, Zhan P, Liu X, Kang D, Chen Z, Zhao X, Wang L, Rong L, Cui Q. Punicalagin is a neuraminidase inhibitor of influenza viruses. J Med Virol 2021;93:3465-72. [PMID: 32827314 DOI: 10.1002/jmv.26449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Loaiza-Cano V, Monsalve-Escudero LM, Filho CDSMB, Martinez-Gutierrez M, Sousa DP. Antiviral Role of Phenolic Compounds against Dengue Virus: A Review. Biomolecules 2020;11:E11. [PMID: 33374457 DOI: 10.3390/biom11010011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Du R, Cooper L, Chen Z, Lee H, Rong L, Cui Q. Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro. Antiviral Res 2021;190:105075. [PMID: 33872675 DOI: 10.1016/j.antiviral.2021.105075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Duncan MC, Onguéné PA, Kihara I, Nebangwa DN, Naidu ME, Williams DE, Balgi AD, Andrae-Marobela K, Roberge M, Andersen RJ, Niikura M, Ntie-Kang F, Tietjen I. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus. Molecules 2020;25:E2903. [PMID: 32599753 DOI: 10.3390/molecules25122903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vincent S, Arokiyaraj S, Saravanan M, Dhanraj M. Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro. Front Mol Biosci 2020;7:613401. [PMID: 33425994 DOI: 10.3389/fmolb.2020.613401] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
7 Jantrapirom S, Hirunsatitpron P, Potikanond S, Nimlamool W, Hanprasertpong N. Pharmacological Benefits of Triphala: A Perspective for Allergic Rhinitis. Front Pharmacol 2021;12:628198. [PMID: 33995026 DOI: 10.3389/fphar.2021.628198] [Reference Citation Analysis]
8 Upadhyay S, Tripathi PK, Singh M, Raghavendhar S, Bhardwaj M, Patel AK. Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease. Phytother Res 2020;34:3411-9. [PMID: 32748969 DOI: 10.1002/ptr.6802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
9 Li BH, Li ZY, Liu MM, Tian JZ, Cui QH. Progress in Traditional Chinese Medicine Against Respiratory Viruses: A Review. Front Pharmacol 2021;12:743623. [PMID: 34531754 DOI: 10.3389/fphar.2021.743623] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Terrier O, Slama-Schwok A. Anti-Influenza Drug Discovery and Development: Targeting the Virus and Its Host by All Possible Means. Adv Exp Med Biol 2021;1322:195-218. [PMID: 34258742 DOI: 10.1007/978-981-16-0267-2_8] [Reference Citation Analysis]
11 Rezvanjoo Z, Raofie F. Nanoparticle Production of Terminalia Chebula Extracts by Expansion of Supercritical Solution (ESS). Int J Nanosci 2021;20:2150037. [DOI: 10.1142/s0219581x2150037x] [Reference Citation Analysis]
12 Mahaboob Ali AA, Bugarcic A, Naumovski N, Ghildyal R. Ayurvedic formulations: Potential COVID-19 therapeutics? Phytomedicine Plus 2022;2:100286. [DOI: 10.1016/j.phyplu.2022.100286] [Reference Citation Analysis]